BLOG

Yoko Maeda
フコキサンチノール15mg点滴とNAD+点滴の違いは?老化研究の最新知見も解説
column (e.g. in newspaper)
2026.10.03
What's the Difference Between a 15 mg Fucoxanthinol IV Drip and a NAD+ IV Drip? An Explanation of the Latest Findings in Aging Research
レタトルチドのダウンタイムは?吐き気などの症状・経過と生活上の注意点を解説
column (e.g. in newspaper)
2026.10.02
What Is the Downtime for Letrozole? An Explanation of Symptoms (Such as Nausea), the Course of the Condition, and Lifestyle Precautions
「筋肉増強剤」とひとくくりにしていいのか──選ぶ前に知っておきたいこと
column (e.g. in newspaper)
2026.09.21
Should We Lump Them All Under the Term “Muscle-Building Supplements”?—What You Should Know Before Choosing One
メチレンブルー点滴と高濃度ビタミンC点滴の違いは?作用や目的を医師が解説
column (e.g. in newspaper)
2026.09.15
What's the Difference Between a Methylene Blue IV and a High-Dose Vitamin C IV? A Doctor Explains Their Effects and Purposes
レタトルチドが向いている人とは?適応や治療を検討するときのポイントを医師が解説
column (e.g. in newspaper)
2026.09.13
Who Is a Good Candidate for Letrortide? A Doctor Explains Key Points to Consider When Evaluating Indications and Treatment Options
レタトルチドの治験はどこまで進んでいる? 最新の状況と承認までの見通し
column (e.g. in newspaper)
2026.09.13
How Far Along Are the Clinical Trials for Letatortide? The Latest Status and Outlook for Approval
GHK-Cu(銅ペプチド)が向いている人とは?適応や施術を検討するときのポイントを医師が解説
column (e.g. in newspaper)
2026.09.11
Who Is GHK-Cu (Copper Peptide) Suitable For? A Doctor Explains Key Points to Consider When Evaluating Suitability and Treatment Options
GHK-Cu(銅ペプチド)と他の育毛治療の違いは?AGA治療との違いや選び方を解説
column (e.g. in newspaper)
2026.09.07
What's the Difference Between GHK-Cu (Copper Peptide) and Other Hair Regrowth Treatments? An Explanation of How It Differs from AGA Treatments and How to Choose the Right One
レタトルチドの半減期はどのくらい? 効果の続き方と治療スケジュールの考え方
column (e.g. in newspaper)
2026.09.07
What is the half-life of letrozole? How long do its effects last, and how should the treatment schedule be planned?
レタトルチド注射とは? 効果の仕組みと、始める前に知っておきたいこと
column (e.g. in newspaper)
2026.09.07
What Is a Letrotide Injection? How It Works and What You Need to Know Before Starting Treatment
レタトルチドとマンジャロの違いは?作用する受容体や臨床試験データ、痩身施術との違いを解説
column (e.g. in newspaper)
2026.09.06
What's the Difference Between Leterolide and Manjalo? An Explanation of Their Target Receptors, Clinical Trial Data, and How They Differ from Weight-Loss Treatments
フコキサンチノール15mg点滴のダウンタイムは?施術後の症状・注意点を医師が解説
column (e.g. in newspaper)
2026.09.05
What Is the Downtime for a 15 mg Fucoxanthinol IV Drip? A Doctor Explains Post-Treatment Symptoms and Precautions
メチレンブルー点滴のダウンタイムは?副作用・リスクや施術後の注意点を医師が解説
column (e.g. in newspaper)
2026.09.04
What Is the Downtime for a Methylene Blue IV? A Doctor Explains Side Effects, Risks, and Post-Treatment Precautions
フコキサンチノール15mg点滴が向いている人とは?適応や施術を検討するときのポイントを医師が解説
column (e.g. in newspaper)
2026.09.02
Who Is a Good Candidate for a 15 mg Fucoxantinol IV Drip? A Doctor Explains the Indications and Key Considerations When Evaluating the Treatment
メチレンブルー点滴が向いている人とは?適応や施術を検討するときのポイントを医師が解説
column (e.g. in newspaper)
2026.09.01
Who Is a Good Candidate for a Methylene Blue Infusion? A Doctor Explains the Indications and Key Considerations When Deciding on the Procedure
WEB Reservation
RESERVATION
24-hour reception
Click here for web reservation